Literature DB >> 17056535

TGFbeta protein processing and activity through TCR triggering of primary CD8+ T regulatory cells.

Antoine Ménoret1, Lara M Myers, Seung-Joo Lee, Robert S Mittler, Robert J Rossi, Anthony T Vella.   

Abstract

In general, TGFbeta is synthesized as a procytokine that requires proteolytic activation, release of the mature cytokine from its noncovalently associated latent-associated peptide, and binding to TGFbetaRII to mediate suppressive activity. We tracked this process in mice containing primed CD8 regulatory T cells (Tregs) by immunoblotting in primary whole cell lysates for pro-TGFbeta, latent-associated peptide and mature TGFbeta. Generation of CD8 Tregs promoted processing of the 50 kDa pro-TGFbeta protein into a 12.5 kDa mature TGFbeta species in vivo. Despite the inability to detect mature TGFbeta in the sera of mice with primed CD8 Tregs and in the synthetic culture medium of stimulated CD8 Tregs, we demonstrated engagement of TGFbetaRII through immunoblotting for Smad2 phosphorylation. This process relied on continual TCR triggering, which also induced Smad3 phosphorylation. To understand the movement of mature TGFbeta, we showed that in contrast to IFN-gamma, mature TGFbeta does not remain a soluble cytokine but is likely to be rapidly adsorbed by neighboring cells. These data show the exquisite local control directed toward TGFbeta by the immune system and underscore the fine specificity involved in its detection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056535     DOI: 10.4049/jimmunol.177.9.6091

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Origins and functional basis of regulatory CD11c+CD8+ T cells.

Authors:  Dass S Vinay; Chang H Kim; Beom K Choi; Byoung S Kwon
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

Review 2.  Emerging concepts in CD8(+) T regulatory cells.

Authors:  Jerry Y Niederkorn
Journal:  Curr Opin Immunol       Date:  2008-04-10       Impact factor: 7.486

3.  Splenic CD8+ T cells secrete TGF-beta1 to exert suppression in mice with anterior chamber-associated immune deviation.

Authors:  Liqiong Jiang; Hao He; Peizeng Yang; Xiaomin Lin; Hongyan Zhou; Xiangkun Huang; Aize Kijlstra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-17       Impact factor: 3.117

4.  Selective PGE(2) suppression inhibits colon carcinogenesis and modifies local mucosal immunity.

Authors:  Masako Nakanishi; Antoine Menoret; Takuji Tanaka; Shingo Miyamoto; David C Montrose; Anthony T Vella; Daniel W Rosenberg
Journal:  Cancer Prev Res (Phila)       Date:  2011-05-16

Review 5.  4-1BB signaling beyond T cells.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Mol Immunol       Date:  2011-01-10       Impact factor: 11.530

Review 6.  TNF superfamily: costimulation and clinical applications.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Biol Int       Date:  2009-02-20       Impact factor: 3.612

7.  Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.

Authors:  Manikandan Subramanian; Edward Thorp; Goran K Hansson; Ira Tabas
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

8.  The oxazolidinone derivative locostatin induces cytokine appeasement.

Authors:  Antoine Ménoret; Jeremy P McAleer; Soo-Mun Ngoi; Swagatam Ray; Nicholas A Eddy; Gabriel Fenteany; Seung-Joo Lee; Robert J Rossi; Bijay Mukherji; David L Allen; Nitya G Chakraborty; Anthony T Vella
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

9.  The suppression of hypersensitivity by ocular-induced CD8(+) T cells requires compatibility in the Qa-1 haplotype.

Authors:  Robert E Cone; Subhasis Chattopadhyay; Roshanak Sharafieh; Yen Lemire; James O'Rourke
Journal:  Immunol Cell Biol       Date:  2009-01-13       Impact factor: 5.126

10.  Exposure of a distinct PDCA-1+ (CD317) B cell population to agonistic anti-4-1BB (CD137) inhibits T and B cell responses both in vitro and in vivo.

Authors:  Dass S Vinay; Seung J Lee; Chang H Kim; Ho Sik Oh; Byoung S Kwon
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.